Mechanisms of ageing: growth hormone, dietary restriction, and metformin

Lancet Diabetes Endocrinol. 2023 Apr;11(4):261-281. doi: 10.1016/S2213-8587(23)00001-3. Epub 2023 Feb 24.

Abstract

Tackling the mechanisms underlying ageing is desirable to help to extend the duration and improve the quality of life. Life extension has been achieved in animal models by suppressing the growth hormone-insulin-like growth factor 1 (IGF-1) axis and also via dietary restriction. Metformin has become the focus of increased interest as a possible anti-ageing drug. There is some overlap in the postulated mechanisms of how these three approaches could produce anti-ageing effects, with convergence on common downstream pathways. In this Review, we draw on evidence from both animal models and human studies to assess the effects of suppression of the growth hormone-IGF-1 axis, dietary restriction, and metformin on ageing.

Publication types

  • Review

MeSH terms

  • Aging
  • Animals
  • Growth Hormone
  • Human Growth Hormone* / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Insulin-Like Growth Factor I / pharmacology
  • Metformin* / pharmacology
  • Metformin* / therapeutic use
  • Quality of Life

Substances

  • Growth Hormone
  • Insulin-Like Growth Factor I
  • Metformin
  • Human Growth Hormone